COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 11 FDA records to the applicant name Microvention, Inc.. It includes 2 original PMA approvals. 4 entries are PMA supplements. 5 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from May 30, 2018 to Oct 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code OPR appears in 5 of the 11 linked filings. The collection spans 4 FDA product codes and 4 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P170032, with 5 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 4 linked filings have a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 35 Enterprise, Aliso Viejo, CA, 92656. Recorded on P170032/S024, decision dated Oct 27, 2026.
Device categories in this collection
Intrasaccular Flow Disruption Device; Intracranial Coil-Assist Stent; Stent, Carotid; Intracranial aneurysm flow diverter.
Changes described in PMA records
The FDA record P170032/S024, dated 2026-10-27, describes a 30-Day Notice for a process change covering manufacturer, sterilizer, packager or supplier. The stated purpose is approval for an alternate supplier of the resin used in the WEB detachment controller housing. The changed item is therefore the resin source for that housing, not the device's clinical use or labeling.
This supplement sits under the original PMA identifier P170032 for a MicroVention intrasaccular flow disruption device in the OPR product code. It is not a new approval of the whole WEB Aneurysm Embolization System. The source does not state resin identity, qualification data, or any conclusion about safety or clinical effectiveness; the reported purpose is regulatory, and independent proof of those outcomes is absent.
FDA approval-order wording
approval for an alternate supplier of the resin used in the WEB detachment controller housing
Oct 27, 2026 · 30-Day NoticeThe FDA record shows a 30-day notice for P170013/S013, supplement reason listed as process change affecting manufacturer, sterilizer, packager or supplier. The stated purpose is to add automated robotic arms to the existing pickling and etching manufacturing processes for the LVIS/LVIS Jr./LVIS EVO intraluminal support device. The identifier ties this to PMA P170013, but the record is a supplement, not a new approval of the whole system, and it is a manufacturing notice rather than an original PMA.
The notice does not specify which manufacturing site is affected, the pickling or etching parameters involved, how the robotic arms integrate with existing steps, or what validation data were submitted. Nothing in the supplied fields reports safety or clinical effectiveness findings; the stated purpose of the change is distinct from proof of those outcomes.
The product is listed under product code QCA in the intracranial coil-assist stent category, with neurology as the specialty and MicroVention, Inc. as applicant.
FDA approval-order wording
to add automated robotic arms to the existing pickling and etchingmanufacturing processes
Sep 16, 2026 · 30-Day NoticeFDA’s recorded scope: Changes include a new automated vision system as an alternate to the existing manual quality inspection process for stent measurement and a change for the delivery pusher core wire.
Jul 7, 2026 · 30-Day NoticeFDA’s recorded scope: approval for a change in supplier of the connector component from Cregana Wilsonville to Medway
May 28, 2026 · 30-Day NoticeFDA’s recorded scope: approval for an alternate manufacturer of the WEB delivery system subassembly at MicroVention Inc.s Costa Rica facility
May 1, 2026 · 30-Day NoticeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.